ELTP
ELITE PHARMACEUTICALS INC /NV/
Key Financials
Operating Income
$49.1M
↑ 150.6%
Gross Profit
$75.0M
↑ 87.2%
Net Income
$44.9M
↑ 1140.0%
Total Assets
$138.3M
↑ 43.5%
EPS (Diluted)
$0.03
↑ Infinity%
Shareholders' Equity
$98.9M
↑ 84.8%
Total Liabilities
$39.4M
↓ 8.1%
Revenue
$148.9M
↑ 77.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/10/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K/A | 8/11/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| 8-K | 8/4/2026 | View on SEC |
| 8-K | 6/29/2026 | View on SEC |
| 10-K | 6/29/2026 | View on SEC |
| 8-K | 6/23/2026 | View on SEC |
| 8-K | 6/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ELTP |
| Company Name | ELITE PHARMACEUTICALS INC /NV/ |
| CIK | 1053369 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | NJ |
| Phone | 2017502646 |